Insiders · FHTX

FHTX insider transactions

Foghorn Therapeutics Inc. (FHTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for FHTX

• 55d
  SEC Form 4 filed by Gottschalk Adrian

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 103d
  SEC Form 4 filed by Chief Financial Officer Maynard Ryan D

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 103d
  SEC Form 3 filed by new insider Maynard Ryan D

  3 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 121d
  SEC Form 4 filed by Chief Executive Officer Gottschalk Adrian

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 125d
  SEC Form 4 filed by Chief People Officer Costa Carlos

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 125d
  SEC Form 4 filed by Chief Legal Officer Lacascia Michael

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 125d
  SEC Form 4 filed by Chief Medical Officer Cardama Alfonso Quintas

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 125d
  SEC Form 4 filed by Chief Business Officer Rivkin Anna

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 125d
  SEC Form 4 filed by Chief Scientific Officer Bellon Steven F.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 143d
  SEC Form 4 filed by Director Flagship Pioneering, Llc

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 202d
  SEC Form 4 filed by Chief Financial Officer Humer Kristian

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 355d
  SEC Form 4 filed by Director Smith Ian F

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 355d
  SEC Form 4 filed by Director Parshall B Lynne

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 355d
  SEC Form 4 filed by Director Mendelsohn Michael

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 355d
  SEC Form 4 filed by Director Lynch Thomas J. Jr.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 355d
  SEC Form 4 filed by Director Gill Simba

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 355d
  SEC Form 4 filed by Director Biller Scott

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 355d
  SEC Form 4 filed by Director Cole Douglas G.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 401d
  SEC Form 4 filed by Director Gallagher Neil

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 401d
  SEC Form 4 filed by Director Duty Stuart

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 401d
  SEC Form 3 filed by new insider Gallagher Neil

  3 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 401d
  SEC Form 3 filed by new insider Duty Stuart

  3 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 405d
  Chief Executive Officer Gottschalk Adrian gifted 300,000 shares and received a gift of 300,000 shares (SEC Form 4)

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 423d
  Chief Executive Officer Gottschalk Adrian gifted 197,906 shares and received a gift of 197,906 shares (SEC Form 4)

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 499d
  SEC Form 4 filed by Chief Medical Officer Cardama Alfonso Quintas

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 499d
  SEC Form 4 filed by Chief Financial Officer Humer Kristian

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 499d
  SEC Form 4 filed by Chief People Officer Costa Carlos

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 499d
  SEC Form 4 filed by Chief Business Officer Rivkin Anna

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 499d
  SEC Form 4 filed by Chief Executive Officer Gottschalk Adrian

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 499d
  SEC Form 4 filed by Chief Scientific Officer Bellon Steven F.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 499d
  SEC Form 4 filed by Chief Legal Officer Lacascia Michael

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 525d
  SEC Form 4 filed by Director Koppel Adam

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 621d
  Chief People Officer Costa Carlos exercised 36,613 shares at a strike of $3.72 and sold $367,706 worth of shares (36,613 units at $10.04) (SEC Form 4)

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 625d
  Chief People Officer Costa Carlos exercised 11,574 shares at a strike of $3.72 and sold $116,319 worth of shares (11,574 units at $10.05) (SEC Form 4)

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 627d
  Chief People Officer Costa Carlos exercised 10,672 shares at a strike of $3.72 and sold $107,131 worth of shares (10,672 units at $10.04) (SEC Form 4)

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 634d
  Chief Scientific Officer Bellon Steven F. sold $190,000 worth of shares (20,000 units at $9.50), decreasing direct ownership by 16% to 101,957 units (SEC Form 4)

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 641d
  SEC Form 4 filed by Chief Business Officer Rivkin Anna

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 641d
  SEC Form 3 filed by new insider Rivkin Anna

  3 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Mendelsohn Michael

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Biller Scott

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Lynch Thomas J. Jr.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Smith Ian F

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Gill Simba

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Cole Douglas G.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Koppel Adam

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 709d
  SEC Form 4 filed by Director Parshall B Lynne

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 713d
  SEC Form 4 filed by Chief Strategy/Bus Ops Officer Cavalie Fanny

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 744d
  SEC Form 4 filed by Flagship Pioneering Inc.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 744d
  SEC Form 3 filed by new insider Flagship Pioneering Fund Vii General Partner Llc

  3 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 781d
  SEC Form 4 filed by Humer Kristian

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 781d
  SEC Form 3 filed by new insider Humer Kristian

  3 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 817d
  Cavalie Fanny sold $72,134 worth of shares (11,000 units at $6.56), decreasing direct ownership by 13% to 75,992 units (SEC Form 4)

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 864d
  SEC Form 4 filed by Gottschalk Adrian

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 864d
  SEC Form 4 filed by Cardama Alfonso Quintas

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 864d
  SEC Form 4 filed by Cavalie Fanny

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 864d
  SEC Form 4 filed by Costa Carlos

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 864d
  SEC Form 4 filed by Bellon Steven F.

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 864d
  SEC Form 4 filed by Lacascia Michael

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 872d
  SEC Form 4 filed by Reine Allan

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)
• 908d
  SEC Form 4 filed by Smith Ian F

  4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)